Latest Research

  1. XY Female
  2. Syndactyly-polydactyly-ear Lobe …
  3. Nonsyndromic Hereditary Sensorineural …
  4. Congenital Unilateral Pulmonary …
  5. Congenital Herpes Simplex
  6. Tolosa-Hunt Syndrome
  7. Rokitansky Sequence
  8. Porokeratosis- Disseminated Superficial …
  9. Kaufman Oculocerebrofacial Syndrome
  10. Senior Loken Syndrome
  11. Amastia
  12. Syndactyly- Type 3

Research

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

Danubian endemic familial nephropathy

  1. Higher apoptotic cell rate in Balkan endemic nephropathy--stereologic analysis.
  2. Epidemiological data regarding Balkan endemic nephropathy in relationship with the Pliocene coal etiological hypothesis.
  3. Role of P450 1A1 and P450 1A2 in Bioactivation versus Detoxication of the Renal Carcinogen Aristolochic Acid I: Studies in Cyp1a1(-/-), Cyp1a2(-/-), and Cyp1a1/1a2(-/-) Mice.
  4. Upper urinary tract transitional cell carcinoma: location is not correlated with prognosis.
  5. Identification and validation of six proteins as marker for endemic nephropathy.
  6. Inhibition of renal NQO1 activity by dicoumarol suppresses nitroreduction of aristolochic acid I and attenuates its nephrotoxicity.
  7. Genetic loci that affect aristolochic acid induced nephrotoxicity in the mouse.
  8. Beta2-microglobulin and alpha1-microglobulin as markers of balkan endemic nephropathy, a worldwide disease.
  9. The human carcinogen aristolochic acid i is activated to form DNA adducts by human NAD(P)H:quinone oxidoreductase without the contribution of acetyltransferases or sulfotransferases.
  10. Time trends in Balkan endemic nephropathy incidence in the most affected region in Serbia, 1977-2009: the disease has not yet disappeared.
  11. TP53 Mutational signature for aristolochic acid: An environmental carcinogen.
  12. Role of Cytochromes P450 1A1/2 in Detoxication and Activation of Carcinogenic Aristolochic Acid I: Studies with the Hepatic NADPH:Cytochrome P450 Reductase Null (HRN) Mouse Model.
  13. Characteristics of upper urothelial carcinoma in an area of Balkan endemic nephropathy in south Serbia. A fifty-year retrospective study.
  14. Metabolic Pathways of Ochratoxin A.
  15. Fifty years of Balkan endemic nephropathy in Romania: some aspects of the endemic focus in the Mehedinti county.
  16. Identification of a reduction product of aristolochic acid: implications for the metabolic activation of carcinogenic aristolochic acid.
  17. Chinese herbal medicines, aristolochic acid and Balkan endemic nephropathy.
  18. High prevalence of kidney disease in two rural communities in Kosovo and Metohia.
  19. Presence of ochratoxin A in Tunisian blood nephropathy patients. Exposure level to OTA.
  20. Linking environmental carcinogen exposure to TP53 mutations in human tumours using the human TP53 knock-in (Hupki) mouse model.